The proportion of patients with T2D is relevant, since weight loss following GLP1-RA therapy is usually greater in patients without T2D [14,15,16,17]
HFpEF is strongly associated with obesity and metabolic dysfunction, and this is the first demonstration that treating the underlying obesity significantly improves HFpEF outcomespotentially establishing a new treatment paradigm
Learn more about our process
As your appetite decreases and the pounds come off, so does your intake of the proteins, vitamins, and minerals your body needs to thrive
Even though the 3D structure of OCTN2 is still not known, the molecular determinants for substrate specificity have been revealed: one ammonium and one carboxylate groups are strictly required for transport, while the distance between them is not important (Ohashi et al., 2002